Atopic dermatitis (AD) is a multifactorial long-standing inflammatory skin disease with a high incidence worldwide in both adults and children.

 

According to the recognized correlation between skin and intestine–the so-called “gut–skin axis”–gut unbalances can affect skin by inducing systemic inflammation and triggering dermatological diseases such as AD.

 

The objectives of the study was to evaluate the efficacy of a food supplement containing selected strains of probiotics in ameliorating AD symptoms and skin conditions in adult volunteers.

What Complife team did:

Among our volunteers they selected 80 adult subjects showing mild-to-severe AD, skin dryness, desquamation, erythema and itching.

 

These people were enrolled in a randomized controlled trial to receive, for 56 days, a placebo or a mixture of lactobacilli (L. plantarum PBS067, L. reuteri PBS072 and L. rhamnosus LRH020).

 

What they obtained:

Subjects receiving the probiotic mixture showed an improvement in skin smoothness, skin moisturization, self-perception, and a decrease in SCORAD index as well as in the levels of inflammatory markers associated with AD.

 

So they could conclude that the administration of selected probiotic strains resulted in a fast and sustained improvement in AD-related symptoms and skin conditions.

 

Link to the complete published article in the European Journal of Dermatology HERE

 

COMPLIFE. COMMITTED TO SCIENCE, COMMITTED TO YOU.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”SERVICES” link=”url:https%3A%2F%2Fwww.complifegroup.com%2Fservices%2F|title:Services”][/vc_column][/vc_row]